| Filed On | Filing |
|---|---|
| 17 Sep 2026 |
Form 4: Meyer Robert J., Director
Granted 31,182 Stock Option (Right to Buy) |
| 05 May 2026 |
Form 4: Novo Holdings A/S, 10% owner
Received 3,327,734 shares by conversion · Bought 555,555 shares ($10M) |
| 05 May 2026 |
Form 4: Fmr Llc, 10% owner
Received 2,284,535 shares by conversion |
| 04 May 2026 |
Form 4: Golden Adam H., General Counsel
Granted 254,891 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Carroll Jill, Director
Received 1,908,784 shares by conversion · Bought 277,778 shares ($5M) |
| 01 May 2026 |
Form 4: Sr One Capital MANAGEMENT, Llc, 10% owner and 1 other
Received 2,753,094 shares by conversion · Bought 555,555 shares ($10M) |
| 01 May 2026 |
Form 4: Congleton Jon, Director
Granted 26,978 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Turner Heather D, Director
Granted 26,978 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Rhodes Melissa, Chief Operating Officer
Granted 211,975 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Carlson Douglas R, Chief Financial Officer
Granted 211,975 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Haviland Kate, Director
Granted 26,978 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Wellington Biomedical Innovation Master Investors (Cayman) Ii L.p., 10% owner
Received 1,275,486 shares by conversion |
| 01 May 2026 |
Form 4: Lazarus Howard, Chief Medical Officer
Granted 211,975 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Lavelle Erin, Director
Granted 26,978 Stock Option (Right to Buy) |
| 01 May 2026 |
Form 4: Baranowski Lyn, Director
Granted 501,033 Stock Option (Right to Buy) |
Loading...
